GeneCentric Therapeutics, Inc. is an RNA-based genomic solutions provider based in Durham, North Carolina. The company designed its technologies to parse the complexity of tumor and immune biology using its RNA-based Tumor and Immune Micro-Environment (rT(I)ME) Explorer platform to discover and develop signatures of responder populations to oncology therapeutics.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/08/21 | $7,500,000 | Series B-1 |
Alexandria Venture Investments Hatteras Venture Partners IAG Capital Partners LabCorp | undisclosed |
